2020
DOI: 10.1186/s10194-020-01188-1
|View full text |Cite
|
Sign up to set email alerts
|

Headache characteristics in COVID-19 pandemic-a survey study

Abstract: Background Headache is the most common COVID-19-related neurological symptom. We aimed to reveal diagnostic clues of headache for COVID-19 infection and to investigate the course of primary headaches during the pandemic. Methods We developed a detailed web-based questionnaire screening the characteristics and course of headaches besides clinical COVID-19 features. The participants were grouped according to being diagnosed with COVID-19 infection or not, and having previous or new-onset headaches. The COVID-1… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

11
108
1
4

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 132 publications
(133 citation statements)
references
References 31 publications
11
108
1
4
Order By: Relevance
“…For example, in a meta-analysis of 86 studies ( n = 14,275), the pooled prevalence of headache was much lower than that of our study (10.1%), with no significant difference in headache prevalence among severe/critically-ill vs. non-severe COVID-19 patents ( p = 0.78) [ 28 ]. Similar to the population in our study, one survey study from Turkey of patients with COVID-19 infection treated in an outpatient setting, found that new-onset headaches occurred in 33% of the population, and more common among those with COVID-19 compared to controls [ 29 ]. Our study has demonstrated a higher prevalence of headache than both of these studies, demonstrating the potential utility of headache as a clinical symptom of COVID-19 infection.…”
Section: Discussionsupporting
confidence: 78%
“…For example, in a meta-analysis of 86 studies ( n = 14,275), the pooled prevalence of headache was much lower than that of our study (10.1%), with no significant difference in headache prevalence among severe/critically-ill vs. non-severe COVID-19 patents ( p = 0.78) [ 28 ]. Similar to the population in our study, one survey study from Turkey of patients with COVID-19 infection treated in an outpatient setting, found that new-onset headaches occurred in 33% of the population, and more common among those with COVID-19 compared to controls [ 29 ]. Our study has demonstrated a higher prevalence of headache than both of these studies, demonstrating the potential utility of headache as a clinical symptom of COVID-19 infection.…”
Section: Discussionsupporting
confidence: 78%
“…Our result showed that stress was a common trigger for migraine in 24% which is similar to result of Uygun who reported that stress was triggers for headache in up to 30% of the participants [19]. Hearing or reading continuously about the COVID-19 from media can be stressful.…”
Section: Discussionsupporting
confidence: 88%
“…For example, in a meta-analysis of 86 studies (n=14,275), the pooled prevalence of headache was much lower than that of our study (10.1%), with no significant difference in headache prevalence among severe/critically-ill vs. non-severe COVID-19 patents (p=0.78) 28 . Similar to the population in our study, one survey study from Turkey of patients with COVID-19 infection treated in an outpatient setting, found that new-onset headaches occurred in 33% of the population, and more common among those with COVID-19 compared to controls 29 .…”
Section: Discussionsupporting
confidence: 85%